|
|
|
|
LEADER |
01935nam a22003375i 4500 |
001 |
000285467 |
005 |
20210824121612.0 |
007 |
cr nn 008mamaa |
008 |
150529s2015 gw | s |||| 0|eng d |
020 |
|
|
|a 9783319181028
|
024 |
7 |
|
|a 10.1007/978-3-319-18102-8
|2 doi
|
040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
245 |
1 |
0 |
|a Histone Recognition /
|c edited by Ming-Ming Zhou.
|
250 |
|
|
|a 1st ed. 2015.
|
260 |
# |
# |
|a Cham :
|b Springer International Publishing :
|b Imprint: Springer,
|c 2015.
|
300 |
|
|
|a VIII, 282 p. 69 illus., 51 illus. in color. :
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
505 |
0 |
|
|a The Bromodomain as the Acetyl-Lysine Binding Domain in Gene Transcription -- PHD Fingers as Histone Readers -- Methyl-Lysine Recognition by the Royal Family Modules: Chromo, Tudor, MBT, Chromo Barrel, and PWWP Domains -- Histone Recognition by WD40 Proteins -- Methyl-Lys Recognition by Ankyrin Repeat Proteins -- Methyl-Arginine Recognition by Tudor Domains -- Histone Recognition by Tandem Modules and Modulation by Multiple PTMs -- Genome-Wide Profiling of Molecular Recognition of Histone PTMs -- BET Bromodomain Inhibition as a Therapeutic Approach in Hematological Malignancies -- Anti-Inflammatory Effects of BET Protein Inhibition Through Modulation of Gene Transcription -- Activating Latent HIV by Inhibiting Bromodomain Proteins -- Small Molecule Modulation of Methyl-Lysine Mediated Interactions.
|
650 |
|
0 |
|a Gene expression.
|
650 |
|
0 |
|a Posttranslational modification.
|
650 |
|
0 |
|a Proteins .
|
650 |
|
0 |
|a Medical genetics.
|
650 |
1 |
4 |
|a Gene Expression.
|
650 |
2 |
4 |
|a Posttranslational Modification.
|
650 |
2 |
4 |
|a Protein-Ligand Interactions.
|
650 |
2 |
4 |
|a Gene Function.
|
700 |
1 |
|
|a Zhou, Ming-Ming.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|